Learn More
Medchemexpress LLC Docetaxel-d9 | 940867-25-4 | 98.65% | C43H44D9NO14 | 1 MG

Supplier: Medchemexpress LLC HYB0011S1MG
Docetaxel-d9 is a deuterium-labeled version of Docetaxel, known to act as a microtubule depolymerization inhibitor. It influences gene expression, causes cell cycle arrest, and induces cell apoptosis, demonstrating anti-cancer activity. Deuteration can influence the pharmacokinetic and metabolic profiles of drugs.
- Used as a tracer
- Used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
- Microtubule depolymerization inhibitor
- Reduces bcl-2 and bcl-xL gene expression
- Arrests cell cycle at G2/M
- Induces cell apoptosis
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.